PHC3-PRKACA was classified as ‘cautionary’ PP-SV, as PHC3 showed a potential cancer suppressor effect in PCa, while PRKACA appears to portray oncogenic behaviour (Supplementary Table 7). This evidence concerns the gene PHC3 and posterior cortical atrophy.